The MarketWatch News Department was not involved in the creation of this content. Results of 244-Patient Study to Support Planned FDA Pre-Market Approval (PMA) Application BOSTON and YOKNEAM, Israel, ...
BOSTON and YOKNEAM, Israel, April 22, 2025 /PRNewswire/ -- Butterfly Medical, a medical device company focused on alleviating suffering in patients with BPH (Benign Prostatic Hyperplasia), announced ...
BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--Butterfly Network, Inc. (“Butterfly”) (NYSE: BFLY), a digital health company transforming care through the power of portable, semiconductor-based ...
The deployment of 500 Butterfly iQ+ probes is part of a larger effort to bring technology and hands-on training to 1,000 mid-level healthcare workers in Sub-Saharan Africa Tens of thousands of scans ...
Cleveland Clinic Urologist Dr. James Ulchaker will Support Efforts Toward FDA Approval and U.S. Commercialization While Contributing to Medical Strategy and Patient-Focused Care BPH affects up to 50 ...
"Butterfly's Ultrasound-on-a-Chip technology enables a low-cost window into the human body, making high-quality diagnostic imaging accessible to anyone," Dr. Jonathan Rothberg, founder and chairman of ...
BOSTON and YOKNEAM, Israel, Jan. 8, 2026 /PRNewswire/ -- Butterfly Medical, developer of a proprietary non-surgical solution for benign prostatic hyperplasia (BPH), today announced the successful ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results